RSS Newsfeed  Your shopping cart.
ECA Academy - Your GMP/GDP Information Source
SEARCH

Search in

Keyword

GMP COURSE

Course No 16684

Pre-course Session: Investigational Medicinal Products (IMP) QP Education Course

20 March 2019, Prague, Czech Republic


Costs:
Non-EQPA/Non-ECA Members: EUR 990,--
EQPA/ECA Members: EUR 890,--
EU GMP Inspectorates: EUR 495,--
(All prices excl. VAT)

If you have any questions, please contact us:
Tel.: +49 (0)6221 / 84 44 0 E-Mail: info@concept-heidelberg.de

Speakers


Dr Susanne Ding, Boehringer Ingelheim, Germany

Sue Mann, Sue Mann Consultancy, U.K.

Brenda Van Assche, Janssen, Belgium



Learning Objectives


This pre-course session provides a detailed overview of the specific characteristics in IMP manufacturing a QP must know to certify IMP batches for the release for clinical trials.


Background


The manufacture of investigational medicinal products (IMPs), including labelling, packaging, testing and certification, is carried out in accordance with the applicable GMP regulations. However, this is not a routine process, since, among other things, manufacturing and packaging procedures might be different for each and every clinical trial.

The Qualified Person (QP) must therefore take into account these particularities and the GMP/GCP interface.

Target Group


New colleagues becoming IMP QPs, QPs looking for continuous training and personnel of CROs and “non-commercial” IMP organisations.

Programme


General introduction
  • Different clinical phases I to IV, focus on patient safety
  • Undefined processes (manufacture, fit for purpose control strategy, etc.)
  • Why use risk assessments & how to apply – vital core
  • of a IMP quality system
  • Diversity: IMP manufacturers, start-ups, academia…
Specific legal requirements for IMPs
  • Clinical Trial Regulation EU No. 536/2014 and the “old” Annex 13 and Directives 2001/20/EC and 2003/94/C
  • The “new” ATMP regulation
GMP meets clinical trials – Differences between IMPs and commercial Products
  • Packaging & labeling
  • Randomization
  • Blinding / placebos
  • Comparators
  • NIMPs / AMPs
  • Where to apply validation activities
  • The Product Specification File (PSF)
  • 3rd country manufacture of IMPs: import and the QP Declaration
Registration
  • IMPD, CTA, IND etc.
  • Regulatory compliance and the two step release procedure
GMP meets GCP
  • Interaction with clinical sites
  • Distribution
  • IRT

 GMP Conferences by Topics
 Quality Assurance
 GMP in Biotechnology
 Microbiology
 Regulatory Affairs
 GMP in Pharmaceutical Development
 Quality Control
 Storage, Distribution, Transportation
 Sterile / Aseptic Manufacturing
 Computer Validation
 Technical Operations
 GMP for APIs and Excipients
 Validation
 Medical Devices
 GMP Basic Training Courses
 Packaging